Raja Sanjeev Kumar Nakka | Immunology and Microbiology | Best Researcher Award

Mr. Raja Sanjeev Kumar Nakka | Immunology and Microbiology | Best Researcher Award

Ragon Institute of MGH, MIT and Harvard | United States

Mr. Rajasanjeev Kumar Nakka is a highly accomplished software engineer and data analyst with over a decade of experience in computer programming, software development, data analytics, and systems design. His career spans a broad spectrum of domains, including enterprise application development, data management, system optimization, and scientific computing, with hands-on expertise in C#, ASP.NET, Java, SQL, and data-driven web technologies. A results-oriented technologist, he is recognized for his ability to transform complex business requirements into robust, scalable, and efficient software solutions across industries ranging from financial systems to biomedical informatics. Mr. Nakka holds a Master of Science in Computer Science from Kansas State University, USA (2007), and a Bachelor of Technology in Computer Science and Engineering from Acharya Nagarjuna University, India (2005). In addition, he is a Microsoft Certified Professional Developer (MCPD) and a Sun Certified Java Programmer (SCJP), affirming his proficiency in advanced programming paradigms and software engineering principles. His continuous learning ethos is reflected in certifications spanning data science, software testing, machine learning, and cybersecurity, underscoring his commitment to professional growth and technological innovation. Throughout his distinguished career, Mr. Nakka has contributed significantly to several high-impact software projects. At the Ragon Institute of MGH, MIT, and Harvard, he currently serves as a Senior Data Analyst, leading the development of the Cellular Immunology Database (CIDB)—a sophisticated data management system integrating genetic, clinical, immunological, and virological datasets to support HIV/AIDS research and vaccine development. His role extends beyond technical development to include project management, computational design, stakeholder engagement, and cross-functional collaboration with leading biomedical researchers. His work has enabled efficient data flow, secure information sharing, and advanced analytical capabilities within one of the world’s foremost medical research institutions. Previously, as a Senior Software Engineer at Confluence (Indecomm Global Services) in Pittsburgh, USA, Mr. Nakka was instrumental in developing and supporting SaaS-enabled financial platforms, including Unity NXT for budgeting, expense management, and fund reporting. His technical leadership in employing ASP.NET MVC, JQuery, Knockout, and CQRS frameworks contributed to enhanced system reliability, scalability, and maintainability. His earlier tenure at CDC Software (India) involved designing and implementing CRM integration systems for Microsoft Office, improving workflow synchronization and user experience for global clients. Mr. Nakka’s early career at CivicPlus (USA) and as a Graduate Teaching Assistant at Kansas State University provided a strong foundation in web architecture, software design, and database engineering, including projects that evaluated J2EE and .NET performance for enterprise web services. His academic and industrial projects have consistently demonstrated strong analytical thinking, attention to quality, and a balance between innovation and practical implementation. Driven by curiosity, precision, and innovation, Mr. Rajasanjeev Kumar Nakka continues to advance the integration of data science, software engineering, and computational intelligence, empowering institutions and industries to harness technology for smarter, data-informed decision-making and impactful digital transformation.

Profiles: OrcidGoogle Scholar 

Featured Publications

Lampou, M., Trull, E. C., Warren, H. M., Ghebremichael, M. S., Nakka, R., Floyd, D. J., et al. (2025). Clinical utility of plasma microbial cell-free DNA surveillance in neutropenic patients with acute myeloid leukemia undergoing outpatient chemotherapy: A case series. Diagnostics, 15(13), 1715. https://doi.org/10.3390/diagnostics15131715

Gandla, S., Nakka, R., Khan, R. A., Salboukh, F., & Ghebremichael, M. (2025). The association between syphilis infection and HIV acquisition and HIV disease progression in Sub-Saharan Africa. Tropical Medicine and Infectious Disease, 10(3), 65. https://doi.org/10.3390/tropicalmed10030065

Gandla, S., Nakka, R., Khan, R. A., Bose, E., & Ghebremichael, M. (2025). Biological and social predictors of HIV-1 RNA viral suppression in ART treated PWLH in Sub-Saharan Africa. Tropical Medicine and Infectious Disease, 10(1), 24. https://doi.org/10.3390/tropicalmed10010024

Irie, W. C., Mahone, A., Nakka, R., & Ghebremichael, M. (2023). Factors associated with comfort discussing PrEP with healthcare providers among Black cisgender women. Tropical Medicine and Infectious Disease, 8(9), 436. https://doi.org/10.3390/tropicalmed8090436

Irie, W., Mahone, A., Nakka, R., & Ghebremichael, M. (2023). Confidence in ability to communicate with sexual partners about PrEP among Black cisgender women. AIDS Education and Prevention, 35(5), 333–346. https://doi.org/10.1521/aeap.2023.35.5.333

Vasudeva, M., Nakka, R., Stock, S., & Ghebremichael, M. (2022). Associations between awareness of sexually transmitted infections (STIs) and prevalence of STIs among Sub-Saharan African men and women. Tropical Medicine and Infectious Disease, 7(8), 147. https://doi.org/10.3390/tropicalmed7080147

Md. Hakimul Haque | Microbiology | Best Researcher Award | 13596

Dr. Md. Hakimul Haque | Microbiology | Best Researcher Award 

Dr. Md. Hakimul Haque | The University of Queensland | Australia

Dr. Md. Hakimul Haque is a research scientist with a PhD in Medicine from Griffith University, Australia, and over 19 years of academic and research experience in microbiology, molecular diagnostics, antimicrobial resistance, and cancer biomarker studies. He is currently a Postdoctoral Research Fellow at The University of Queensland and an Adjunct Research Fellow at James Cook University. Dr. Haque has authored 51 peer-reviewed publications, developed innovative biosensor technologies, and led multiple funded research projects on antimicrobial resistance and biosensing applications. His work integrates microbiology, nanotechnology, and translational research to advance diagnostic innovations and improve public health outcomes.

Author Profile 

Scopus

Education

Dr. Md. Hakimul Haque’s academic journey began with a strong foundation in veterinary medicine and microbiology, where he excelled as a top-performing student. His early interests lay in the study of infectious diseases and the molecular mechanisms that drive pathogen behavior. This curiosity pushed him towards advanced research on molecular detection methods, microbial pathogenesis, and antimicrobial resistance. His postgraduate studies further deepened his expertise, focusing on clinical microbiology, molecular diagnostics, and the application of innovative laboratory techniques. From the outset, Dr. Haque demonstrated not only scholarly excellence but also a passion for applying science to address pressing public health issues, particularly in infectious disease surveillance and diagnostics.

Experience

Building upon his academic foundation, Dr. Haque has pursued an extensive professional career spanning teaching, research, and clinical practice. He has served in various academic and scientific capacities, contributing both as a lecturer and as a mentor to postgraduate students. His transition to research-intensive roles has seen him work at the interface of microbiology, nanotechnology, and biomedical science. At The University of Queensland, he continues to engage in groundbreaking projects that explore biosensor development, biomarker extraction, and electrochemical diagnostics. His professional engagements have not only advanced his own expertise but have also fostered collaboration across disciplines, connecting veterinary science, human medicine, and bioengineering.

Research Focus

Dr. Haque’s research portfolio is both broad and impactful. His work centers on molecular diagnostics, antimicrobial resistance, and cancer biomarkers, with a particular emphasis on the development of biosensing technologies. By integrating microbiology with nanotechnology, he has pioneered innovative diagnostic tools that allow for rapid, sensitive, and cost-effective disease detection. His contributions extend to both human and animal health, reflecting a true “One Health” approach. Through the development of electrochemical biosensors and novel detection techniques, Dr. Haque has opened new pathways for identifying drug-resistant pathogens and cancer-related biomarkers, offering potential solutions to some of the most urgent challenges in global health. His more than 50 peer-reviewed publications and multiple book chapters highlight his scholarly productivity and commitment to advancing biomedical sciences.

 Accolades and Recognition

Throughout his career, Dr. Haque has been recognized for his excellence in both teaching and research. He has received multiple awards for high-impact publications, including recognition from prestigious organizations and international funding bodies. His academic success has been supported by competitive research scholarships, which enabled him to pursue advanced studies in Australia and conduct world-class research in cancer diagnostics and biosensing. In addition, he has been trusted with leadership roles in professional associations and review committees, where his expertise continues to shape scientific discourse and guide future research. These accolades reflect his dual strength as both a scientist and an academic leader.

Impact and Influence

The influence of Dr. Haque’s work extends far beyond academic publications. His studies on antimicrobial resistance directly inform public health strategies, especially in regions where resistant pathogens pose significant risks to human and animal health. His diagnostic innovations are designed to be practical and accessible, ensuring that advanced technologies can reach clinical and field settings worldwide. By mentoring graduate students, he has also contributed to capacity building in microbiology and biomedical sciences, nurturing the next generation of researchers. His collaborations with international partners reinforce his role as a global scientist whose work bridges disciplines, geographies, and societal needs.

Publications

First Molecular Characterization and Antibiogram of Bacteria Isolated from Dairy Farm Wastewater in Bangladesh.

Author: M. S. Islam, M. A. Polash, M. H. Hague
Journal: Veterinary medicine international
Year: 2025

Risk factors and antibiogram of human uropathogens in the northern part of Bangladesh: A crosssectional study.

Author: M. F. Islam, D. K. Das, M. H. Hague
Journal: Applied biology and biotechnology
Year: 2024

A simple, inexpensive and portable on-farm test for pregnancy diagnosis and ovary status in cows via chemical analysis of urine.

Author: M. H. Haque, S. Narayan, M. S. Islam
Journal: Biochemical and biophysical research communications
Year: 2023

Conclusion

Dr. Md. Hakimul Haque stands as a distinguished researcher whose journey reflects unwavering dedication to science, education, and global health. His pioneering work in molecular diagnostics, antimicrobial resistance, and biosensor technology has not only advanced biomedical research but also created tangible pathways for improving clinical outcomes. With a proven record of impactful publications, funded projects, and mentorship, he continues to shape the scientific community both in Australia and internationally. Looking to the future, Dr. Haque’s vision is clear—leveraging innovation and collaboration to address urgent health challenges and inspire the next generation of researchers. His career is a remarkable blend of academic brilliance, practical innovation, and a profound commitment to the betterment of society.